Desipramine

CAT:
804-HY-B1272A
Size:
1 Each

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Desipramine - image 1

Desipramine

  • Description :

    Desipramine is a tricyclic psychotic compound, possessing antidepressant activity. Desipramine inhibits the norepinephrine reuptake receptor in the central nervous system and reduces the sleep-related loss of genioglossus activity, can be used to research the improvement of pharyngeal collapsibility[1][2].
  • UNSPSC :

    12352005
  • Hazard Statement :

    H315-H319-H320
  • Target :

    Adrenergic Receptor
  • Type :

    Reference compound
  • Related Pathways :

    GPCR/G Protein; Neuronal Signaling
  • Applications :

    Neuroscience-Neuromodulation
  • Field of Research :

    Neurological Disease; Cancer
  • Assay Protocol :

    https://www.medchemexpress.com/desipramine.html
  • Solubility :

    10 mM in DMSO
  • Smiles :

    CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31
  • Molecular Formula :

    C18H22N2
  • Molecular Weight :

    266.38
  • Precautions :

    P264-P280-P302+P352-P305+P351+P338-P362
  • References & Citations :

    [1]Garcia AS, et al. Autoreceptor-mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment. J Neurochem. 2004 Nov;91 (3) :683-93.|[2]Taranto-Montemurro L, et al. Desipramine improves upper airway collapsibility and reduces OSA severity in patients with minimal muscle compensation. Eur Respir J. 2016 Nov;48 (5) :1340-1350.
  • Shipping Conditions :

    Room temperature
  • Scientific Category :

    Reference compound1
  • Clinical Information :

    Launched
  • Citation 01 :

    Research Square Print. 2023 Feb 23.|Biochim Biophys Acta Mol Basis Dis. 2023 Mar 28;1869 (5) :166700.|Br J Pharmacol. 2024 Dec;181 (23) :4874-4889.|Cell. 2025 Oct 24:S0092-8674 (25) 01131-6.|Glia. 2022 Nov;70 (11) :2093-2107.|Inflammation. 2021 Aug;44 (4) :1592-1606.|J Parkinson Dis. 2020;10 (2) :523-542.|Neural Regen Res. 2021 Aug;16 (8) :1660-1670.|Neuroscience. 2024 Mar 26:542:11-20.|Neurotoxicology. 2022 Dec:93:173-185.|Parkinsons Dis. 2022 Nov 14:2022:1428817.|Pharmaceutics. 2022 Jul 22;14 (8) :1523.|Sci Total Environ. 2024 May 1:923:171405.
  • CAS Number :

    [50-47-5]

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide